CID 57524407

Apremilast metabolite m21

Structural Information

Molecular Formula
C19H18N2O8S
SMILES
CS(=O)(=O)C[C@H](C1=CC(=C(C=C1)O)O)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)CO
InChI
InChI=1S/C19H18N2O8S/c1-30(28,29)9-13(10-5-6-14(23)15(24)7-10)21-18(26)11-3-2-4-12(17(11)19(21)27)20-16(25)8-22/h2-7,13,22-24H,8-9H2,1H3,(H,20,25)/t13-/m1/s1
InChIKey
QDXBFGPTCLXDON-CYBMUJFWSA-N
Compound name
N-[2-[(1S)-1-(3,4-dihydroxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]-2-hydroxyacetamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

7
Patents

434.0784 Da
Monoisotopic Mass

0.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 435.08568 195.3
[M+Na]+ 457.06762 201.6
[M-H]- 433.07112 198.2
[M+NH4]+ 452.11222 204.1
[M+K]+ 473.04156 198.0
[M+H-H2O]+ 417.07566 189.2
[M+HCOO]- 479.07660 205.7
[M+CH3COO]- 493.09225 222.9
[M+Na-2H]- 455.05307 194.7
[M]+ 434.07785 199.6
[M]- 434.07895 199.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe